Pharmacological Study of IQM-97,423, a Potent and Selective CCK1 Receptor Antagonist with Protective Effect in Experimental Acute Pancreatitis

Miriam Latorre,J.M. Bartolomé-Nebreda,M.T. García-López,Rosario González-Muñiz,Rosario Herranz,J. Del Río,Edurne Cenarruzabeitia

Pharmacological Study of IQM-97,423, a Potent and Selective CCK1 Receptor Antagonist with Protective Effect in Experimental Acute Pancreatitis

2004

Miriam Latorre
J.M. Bartolomé-Nebreda
M.T. García-López
Rosario González-Muñiz
Rosario Herranz
J. Del Río
Edurne Cenarruzabeitia

The pharmacological profile of the new CCK1 receptor antagonist IQM-97,423, (4a S ,5 R )-2-benzyl-5-(tert-butylaminocarbonyl-tryptophyl)amino-1,3-dioxoperh

Keywords:

Enzyme
Acute pancreatitis
Diabetes mellitus
Receptor antagonist
Endocrinology
Internal medicine
Amylase release
Enzyme assay
Guinea pig
Cholecystokinin
Chemistry
cck1 receptor
Antagonist

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations